# Mesoblast Limited (MESO)

> Healthcare · AU · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MESO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | N/A | N/A | $ -4.46M | N/A | N/A |
| 2025 | $ 14.38M | $ -55.50M | $ -60.09M | $ 135.14M | $ 574.68M |
| 2024 | $ 5.96M | $ -108.63M | $ -21.95M | $ 126.11M | $ 461.26M |
| 2023 | $ 8.07M | $ -78.99M | $ -65.24M | $ 122.00M | $ 508.73M |
| 2022 | $ 8.55M | $ -93.98M | $ -67.52M | $ 111.78M | $ 500.00M |
| 2021 | $ 11.75M | $ -115.50M | $ -28.10M | $ 103.18M | $ 535.51M |
| 2020 | $ 20.76M | $ -124.98M | $ -129.47M | $ 99.72M | $ 518.73M |
| 2019 | $ 28.47M | $ -97.79M | $ -74.92M | $ 94.30M | $ 500.80M |
| 2018 | $ 21.39M | $ -113.68M | $ -75.92M | $ 63.48M | $ 524.56M |
| 2017 | $ 21.45M | $ -40.80M | $ -113.82M | $ 0 | $ 575.61M |
| 2016 | $ 43.98M | $ -11.68M | $ -119.54M | $ 0 | $ 510.52M |
| 2015 | $ 33.60M | $ -156.45M | $ -160.96M | $ 0 | $ 492.75M |
| 2014 | $ 23.03M | $ -127.32M | $ -118.55M | $ 0 | $ 584.87M |
| 2013 | $ 53.60M | $ -87.10M | $ -103.73M | $ 0 | $ 637.76M |
| 2012 | $ 22.08M | $ -41.64M | $ -38.77M | $ 0 | $ 453.52M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.24 |
| Liabilities / Eq | 0.36 |
| Current Ratio | 1.58 |

## Other views

- [Metrics](https://sponda.capital/en/MESO.md)
- [Charts](https://sponda.capital/en/MESO/charts.md)
- [Compare](https://sponda.capital/en/MESO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.